{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:55:07Z","timestamp":1793962507880,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1136\/ard.2007.076232","type":"journal-article","created":{"date-parts":[[2007,11,3]],"date-time":"2007-11-03T00:34:45Z","timestamp":1194050085000},"page":"960-966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":400,"title":["Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u00e2\u20ac\u201c2005"],"prefix":"10.1016","volume":"67","author":[{"given":"L","family":"Annemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Spaepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gaskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bonnemaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Malier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Nuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.076232_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","article-title":"Serum urate levels and gout flares: analysis from managed care data.","volume":"12","author":"Sarawate","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/ard.2007.076232_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"10.1136\/ard.2007.076232_bib3","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout.","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2007.076232_bib4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.076232_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0033-8389(03)00158-1","article-title":"Gout: a clinical and radiologic review.","volume":"42","author":"Monu","year":"2004","journal-title":"Radiol Clin North Am"},{"key":"10.1136\/ard.2007.076232_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout - Part I Diagnosis: Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.076232_bib7","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout - Part II Management: Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.076232_bib8","first-page":"577","article-title":"Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?","volume":"28","author":"Li-Yu","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.076232_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/art.20405","article-title":"A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy.","volume":"51","author":"Shoji","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.076232_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","article-title":"Gout epidemiology: results from the UK General Practice Research Database, 1990\u00e2\u20ac\u201c1999.","volume":"64","author":"Mikuls","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.076232_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1524-4733.2006.00139.x","article-title":"A checklist for medication compliance and persistence studies using retrospective databases.","volume":"10","author":"Peterson","year":"2007","journal-title":"Value Health"},{"key":"10.1136\/ard.2007.076232_bib12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0895-4356(94)00244-K","article-title":"The prevalence and prophylaxis of gout in England.","volume":"48","author":"Harris","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ard.2007.076232_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/ard.38.2.101","article-title":"Prevalence and incidence of the diagnosis of gout in Great Britain.","volume":"38","author":"Currie","year":"1979","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.076232_bib14","unstructured":"Adams PF, Hendershot GE, Marano MA,. Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics. Vital Health Stat 10, 1999;, (200):1\u00e2\u20ac\u201c2003."},{"key":"10.1136\/ard.2007.076232_bib15","first-page":"1582","article-title":"Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population.","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.076232_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0889-857X(21)00887-5","article-title":"Gout and hyperuricemia.","volume":"16","author":"Roubenoff","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.2007.076232_bib17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/rheumatology\/41.7.793","article-title":"The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century.","volume":"41","author":"Symmons","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2007.076232_bib18","unstructured":"World Health Organization,. The SuRF Report 2. Surveillance of chronic disease risk factors. WHO: Geneva 2005 Available at http:\/\/www.heartstats.org\/temp\/Tabsp11.14spweb07.xls (accessed 120 March 2008)."},{"key":"10.1136\/ard.2007.076232_bib19","unstructured":"International Diabetes Federation,. (2003) The diabetes atlas., 2nd ed. Brussels: International Diabetes Federation, 2003. http:\/\/www.heartstats.org\/temp\/ESspTabsp11.2spweb05.xls (accessed 20 March 2008)."},{"key":"10.1136\/ard.2007.076232_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0954-6820.1941.tb11897.x","article-title":"One hundred gouty patients.","volume":"106","author":"Brochner-Mortensen","year":"1941","journal-title":"Acta Med Scand"},{"key":"10.1136\/ard.2007.076232_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/ard.29.5.461","article-title":"Clinical survey of 354 patients with gout.","volume":"29","author":"Grahame","year":"1970","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.076232_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey.","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.076232_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.rhu.0000147049.12220.32","article-title":"Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricaemia in a managed care setting.","volume":"10","author":"Riedel","year":"2004","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/ard.2007.076232_bib24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Johnson","year":"2003","journal-title":"Hypertension"},{"key":"10.1136\/ard.2007.076232_bib25","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction.","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.076232_bib26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archinte.165.7.742","article-title":"Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.","volume":"165","author":"Choi","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2007.076232_bib27","unstructured":"Jordan KM, Cameron S, Snaith M,. British Society for Rheumatology and British health professionals in rheumatology guideline for the management of gout. Rheumatology (Oxford) (in press)."},{"key":"10.1136\/ard.2007.076232_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout.","volume":"143","author":"Choi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2007.076232_bib29","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/ard.2005.040360","article-title":"Gout, not induced by diuretics? A case-control study from primary care.","volume":"65","author":"Janssens","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.076232_bib30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.57.9.545","article-title":"Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.","volume":"57","author":"Perez-Ruiz","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.076232_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/art.1780340203","article-title":"Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout.","volume":"34","author":"Pascual","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.076232_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.","volume":"76","author":"Hande","year":"1984","journal-title":"Am J Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724386649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724386649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.076232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T02:51:11Z","timestamp":1736131871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724386649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0003496724386649"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.076232","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u00e2\u20ac\u201c2005","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.076232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}